Mordor Intelligence - Healthcare & Life Sciences Practice
Our experts study how scientific progress, technology adoption and patient needs are changing healthcare markets. Their research helps organizations assess emerging opportunities, competitive developments and the commercial implications of new products, diagnostics and care models.
Team Size (2025): 20+ & growing
View our Clients
Coverage: Global • 5 regions • 75 countries • 5000+ Reports
Working on something in this sector?
Contact the TeamHealthcare & Life Sciences Practice - Meet Some of Our Experts
Leadership
Featured Experts
Preet Kaur
Lead Analyst
Punit Dilip Varma
Research Analyst
Mahima Shukla
Research Analyst
Yodha Bandi
Research Analyst
Some of Our Team's Published Research and Citations
Pharmaceutical Research Spotlight
Discover pharmaceutical research associated with Yodha Bandi in the World Journal of Pharmacy and Ph...
A Brief Review on Lysozyme’s Pharmacology and Drug-Carrying Capacity
A review co-authored by Punit Dilip Varma on lysozyme's therapeutic uses and its potential as a kidn...
Research Spotlight: Mahima Shukla
Explore a research publication associated with Mahima Shukla on IEEE Xplore.
Our Clients
What We Cover
Markets
Regions
- Global
- North America
- Europe
- Asia-Pacific
- Middle East & Africa
- South America
Research expertise - including but not limited to
Latest Updates from Healthcare & Life Sciences Practice
- Preclinical Imaging Market - Updated on 25/09/2026
- Small Molecule Drug Discovery Market - Updated on 21/09/2026
- Over The Counter Drugs Market - Updated on 17/09/2026
- Hereditary Deafness Market - Updated on 11/09/2026
- Oral Cancer Rapid Test Kit Market - Updated on 11/09/2026
- Healthcare Reimbursement Market - Updated on 11/09/2026
- Molecular Diagnostics Market - Updated on 11/09/2026
- Oral Care Products Market - Updated on 07/09/2026
- Global T-Cell Lymphoma Market - Updated on 09/01/2026
- Urinary Tract Infection Therapeutics Market - Updated on 09/01/2026
When decisions matter, industry leaders turn to our analysts. Let’s talk.